Division of Abbott Medical Optics Inc./OptiMedica Corp.
Latest From OptiMedica Corp.
According to a recent Medtech Insight report, the US market for ophthalmic surgical systems totaled almost $1.7 billion in 2013, and is expected to experience healthy – if moderate – growth over the next five years, reaching an estimated $2.26 billion by 2018.
To stave off the sluggish growth in established markets, multinational medtechs not only are finding new business in countries with booming health care industries but they’re also forging new ways to serve customers. Device companies now are pushing into services, such as disease management, and angling to compete more aggressively on pricing.
Device and diagnostics companies both suffered declines in fundraising compared with previous quarters. The biggest medtech acquisition was Stryker’s $1.4 billion buyout of MAKO, while in diagnostics BioMeriux’s $450 million purchase of BioFire topped the list.
Propelled by the completion of two large acquisitions, the previous quarter was a strong one for device industry M&A activity, and indicators suggest the deal making will continue, PricewaterhouseCoopers says.
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Abbott Medical Optics Inc.
- Johnson & Johnson
- Senior Management
Mark A Murray, CFO
Robert P Eno, VP, Global Mktg. & Int'l.Sales
David D Scott, VP, R&D
- Contact Info
Phone: (408) 850-8600
1310 Moffett Park Dr.
Sunnyvale, CA 94089
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.